
North America Cat Vaccine Market Size, Share & Trends Analysis Report By Component, By Route of Administration (Injectables, Intranasal, and Oral), By Duration of Immunity, By Disease Type, By Type, By Country and Growth Forecast, 2024 - 2031
Description
North America Cat Vaccine Market Size, Share & Trends Analysis Report By Component, By Route of Administration (Injectables, Intranasal, and Oral), By Duration of Immunity, By Disease Type, By Type, By Country and Growth Forecast, 2024 - 2031
The North America Cat Vaccine Market would witness market growth of 8.7% CAGR during the forecast period (2024-2031).
The US market dominated the North America Cat Vaccine Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $637.8 million by 2031. The Canada market is experiencing a CAGR of 11% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 10.1% during (2024 - 2031).
The market has been experiencing significant growth, driven by many factors ranging from increasing pet ownership to advancements in veterinary medicine. As the understanding of feline health continues to expand, the importance of vaccinations in safeguarding the well-being of cats has become increasingly evident. The increasing number of households adopting cats as pets is one of the most significant factors driving the growth of the market. People are increasingly recognizing the companionship and emotional benefits pets, particularly cats, can provide. Vaccinations are essential for preventing various infectious diseases affecting cats, ensuring they lead healthy and fulfilling lives.
Greater awareness about the importance of pet vaccinations has been a driving force in encouraging more pet owners to vaccinate their cats. This heightened awareness is primarily attributable to the initiatives of veterinary organizations and pet health campaigns, which underscore the critical role of vaccinations in the prevention of diseases. These initiatives have successfully educated pet owners about the benefits of vaccinations, leading to higher vaccination rates and healthier pets.
In Mexico, the demand for cat vaccines is increasing due to heightened public health concerns and growing pet ownership. The National Institute of Statistics and Geography (INEGI) reported that pet ownership, including cats, has increased in urban areas. Public health initiatives aimed at controlling rabies, such as the annual National Vaccination Week, have been crucial in promoting the importance of pet vaccinations. These campaigns, supported by the Ministry of Health, provide free or low-cost rabies vaccinations for pets, significantly boosting vaccination rates. Hence, rising pet ownership, increasing awareness of pet health, and a focus on preventative care are expected to continue driving the regional market forward.
Based on Component, the market is segmented into Combined Vaccines, and Mono Vaccines. Based on Route of Administration, the market is segmented into Injectables, Intranasal, and Oral. Based on Duration of Immunity, the market is segmented into 1 Year, 3 Year, and Others. Based on Disease Type, the market is segmented into Feline Respiratory Diseases, Feline Rabies, Feline Panleukopenia (Feline Distemper), Feline Leukemia, and Others. Based on Type, the market is segmented into Modified/Attenuated Live, Inactivated (Killed), and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Zoetis, Inc.
- Elanco Animal Health, Inc.
- Merck & Co., Inc.
- Boehringer Ingelheim International GmbH
- Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
- Virbac
- Heska Corporation (Antech Diagnostics, Inc)
- Ceva Sante Animale
- Bioveta, a.s.
By Component
- Combined Vaccines
- Mono Vaccines
- Injectables
- Intranasal
- Oral
- 1 Year
- 3 Year
- Others
- Feline Respiratory Diseases
- Feline Rabies
- Feline Panleukopenia (Feline Distemper)
- Feline Leukemia
- Others
- Modified/Attenuated Live
- Inactivated (Killed)
- Others
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
120 Pages
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Cat Vaccine Market, by Component
- 1.4.2 North America Cat Vaccine Market, by Route of Administration
- 1.4.3 North America Cat Vaccine Market, by Duration of Immunity
- 1.4.4 North America Cat Vaccine Market, by Disease Type
- 1.4.5 North America Cat Vaccine Market, by Type
- 1.4.6 North America Cat Vaccine Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- 3.3 Porter Five Forces Analysis
- Chapter 4. Strategies Deployed in Cat Vaccine Market
- Chapter 5. North America Cat Vaccine Market by Component
- 5.1 North America Combined Vaccines Market by Region
- 5.2 North America Mono Vaccines Market by Region
- Chapter 6. North America Cat Vaccine Market by Route of Administration
- 6.1 North America Injectables Market by Country
- 6.2 North America Intranasal Market by Country
- 6.3 North America Oral Market by Country
- Chapter 7. North America Cat Vaccine Market by Duration of Immunity
- 7.1 North America 1 Year Market by Country
- 7.2 North America 3 Year Market by Country
- 7.3 North America Others Market by Country
- Chapter 8. North America Cat Vaccine Market by Disease Type
- 8.1 North America Feline Respiratory Diseases Market by Country
- 8.2 North America Feline Rabies Market by Country
- 8.3 North America Feline Panleukopenia (Feline Distemper) Market by Country
- 8.4 North America Feline Leukemia Market by Country
- 8.5 North America Others Market by Country
- Chapter 9. North America Cat Vaccine Market by Type
- 9.1 North America Modified/Attenuated Live Market by Country
- 9.2 North America Inactivated (Killed) Market by Country
- 9.3 North America Others Market by Country
- Chapter 10. North America Cat Vaccine Market by Country
- 10.1 US Cat Vaccine Market
- 10.1.1 US Cat Vaccine Market by Component
- 10.1.2 US Cat Vaccine Market by Route of Administration
- 10.1.3 US Cat Vaccine Market by Duration of Immunity
- 10.1.4 US Cat Vaccine Market by Disease Type
- 10.1.5 US Cat Vaccine Market by Type
- 10.2 Canada Cat Vaccine Market
- 10.2.1 Canada Cat Vaccine Market by Component
- 10.2.2 Canada Cat Vaccine Market by Route of Administration
- 10.2.3 Canada Cat Vaccine Market by Duration of Immunity
- 10.2.4 Canada Cat Vaccine Market by Disease Type
- 10.2.5 Canada Cat Vaccine Market by Type
- 10.3 Mexico Cat Vaccine Market
- 10.3.1 Mexico Cat Vaccine Market by Component
- 10.3.2 Mexico Cat Vaccine Market by Route of Administration
- 10.3.3 Mexico Cat Vaccine Market by Duration of Immunity
- 10.3.4 Mexico Cat Vaccine Market by Disease Type
- 10.3.5 Mexico Cat Vaccine Market by Type
- 10.4 Rest of North America Cat Vaccine Market
- 10.4.1 Rest of North America Cat Vaccine Market by Component
- 10.4.2 Rest of North America Cat Vaccine Market by Route of Administration
- 10.4.3 Rest of North America Cat Vaccine Market by Duration of Immunity
- 10.4.4 Rest of North America Cat Vaccine Market by Disease Type
- 10.4.5 Rest of North America Cat Vaccine Market by Type
- Chapter 11. Company Profiles
- 11.1 Zoetis, Inc.
- 11.1.1 Company Overview
- 11.1.2 Financial Analysis
- 11.1.3 Regional Analysis
- 11.1.4 Research & Development Expenses
- 11.1.5 Recent strategies and developments:
- 11.1.5.1 Partnerships, Collaborations, and Agreements:
- 11.1.5.2 Product Launches and Product Expansions:
- 11.1.5.3 Acquisition and Mergers:
- 11.1.6 SWOT Analysis
- 11.2 Elanco Animal Health, Inc.
- 11.2.1 Company Overview
- 11.2.2 Financial Analysis
- 11.2.3 Regional Analysis
- 11.2.4 Research & Development Expenses
- 11.2.5 SWOT Analysis
- 11.3 Merck & Co., Inc.
- 11.3.1 Company Overview
- 11.3.2 Financial Analysis
- 11.3.3 Segmental and Regional Analysis
- 11.3.4 Research & Development Expenses
- 11.3.5 SWOT Analysis
- 11.4 Boehringer Ingelheim International GmbH
- 11.4.1 Company Overview
- 11.4.2 Financial Analysis
- 11.4.3 Regional & Segmental Analysis
- 11.4.4 Research & Development Expenses
- 11.4.5 Recent strategies and developments:
- 11.4.5.1 Trials and Approvals:
- 11.4.6 SWOT Analysis
- 11.5 Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
- 11.5.1 Company Overview
- 11.5.2 SWOT Analysis
- 11.6 Virbac
- 11.6.1 Company Overview
- 11.6.2 Financial Analysis
- 11.6.3 Regional Analysis
- 11.6.4 Recent strategies and developments:
- 11.6.4.1 Acquisition and Mergers:
- 11.6.5 SWOT Analysis
- 11.7 Heska Corporation (Antech Diagnostics, Inc)
- 11.7.1 Company Overview
- 11.7.2 SWOT Analysis
- 11.8 Ceva Sante Animale
- 11.8.1 Company Overview
- 11.8.2 SWOT Analysis
- 11.9 Bioveta, a.s.
- 11.9.1 Company Overview
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.